Xu Xianbin, Gong Kai, Hong Liang, Yu Xia, Tu Huilan, Lan Yan, Yao Junjie, Ye Shaoheng, Weng Haoda, Li Zhiwei, Shi Yu, Sheng Jifang
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, Zhejiang, China.
Department of Infectious Diseases, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, Zhejiang, China.
BMC Gastroenterol. 2024 May 3;24(1):153. doi: 10.1186/s12876-024-03249-0.
Liver diseases were significant source of early readmission burden. This study aimed to evaluate the 30-day unplanned readmission rates, causes of readmissions, readmission costs, and predictors of readmission in patients with acute liver failure (ALF).
Patients admitted for ALF from 2019 National Readmission Database were enrolled. Weighted multivariable logistic regression models were applied and based on Directed Acyclic Graphs. Incidence, causes, cost, and predictors of 30-day unplanned readmissions were identified.
A total of 3,281 patients with ALF were enrolled, of whom 600 (18.3%) were readmitted within 30 days. The mean time from discharge to early readmission was 12.6 days. The average hospital cost and charge of readmission were $19,629 and $86,228, respectively. The readmissions were mainly due to liver-related events (26.6%), followed by infection (20.9%). The predictive factors independently associated with readmissions were age, male sex (OR 1.227, 95% CI 1.023-1.472; P = 0.028), renal failure (OR 1.401, 95% CI 1.139-1.723; P = 0.001), diabetes with chronic complications (OR 1.327, 95% CI 1.053-1.672; P = 0.017), complicated hypertension (OR 1.436, 95% CI 1.111-1.857; P = 0.006), peritoneal drainage (OR 1.600, 95% CI 1.092-2.345; P = 0.016), etc. CONCLUSIONS: Patients with ALF are at relatively high risk of early readmission, which imposes a heavy medical and economic burden on society. We need to increase the emphasis placed on early readmission of patients with ALF and establish clinical strategies for their management.
肝脏疾病是早期再入院负担的重要来源。本研究旨在评估急性肝衰竭(ALF)患者的30天非计划再入院率、再入院原因、再入院费用以及再入院的预测因素。
纳入2019年国家再入院数据库中因ALF入院的患者。应用基于有向无环图的加权多变量逻辑回归模型。确定30天非计划再入院的发生率、原因、费用和预测因素。
共纳入3281例ALF患者,其中600例(18.3%)在30天内再入院。出院至早期再入院的平均时间为12.6天。再入院的平均住院费用和收费分别为19,629美元和86,228美元。再入院主要是由于肝脏相关事件(26.6%),其次是感染(20.9%)。与再入院独立相关的预测因素包括年龄、男性(OR 1.227,95% CI 1.023 - 1.472;P = 0.028)、肾衰竭(OR 1.401,95% CI 1.139 - 1.723;P = 0.001)、伴有慢性并发症的糖尿病(OR 1.327,95% CI 1.053 - 1.672;P = 0.017)、复杂性高血压(OR 1.436,95% CI 1.111 - 1.857;P = 0.006)、腹腔引流(OR 1.600,95% CI 1.092 - 2.345;P = 0.016)等。结论:ALF患者早期再入院风险相对较高,给社会带来沉重的医疗和经济负担。我们需要更加重视ALF患者的早期再入院,并制定针对他们的临床管理策略。